Status:
UNKNOWN
Social Prescription and Lifestyles Modification to Reduce Glycemia in People With Prediabetes (PREDIBAL)
Lead Sponsor:
University of the Balearic Islands
Conditions:
PreDiabetes
Eligibility:
All Genders
25-75 years
Phase:
NA
Brief Summary
This study aims to evaluate the effectiveness and cost-utility of an intervention based on the social prescription of health assets to modify lifestyles and reduce blood glucose values in prediabetic ...
Detailed Description
No pragmatic clinical trial evaluating the effectiveness of prevention interventions has been performed to date. Social prescription is a useful health promotion strategy that facilitates the continui...
Eligibility Criteria
Inclusion
- Fasting basal blood glucose levels between 100 and \< 126 mg/dl or HbA1c between 5.7 - 6.4%
Exclusion
- Patients with T2D or in treatment with oral antidiabetic drugs
- Institutionalized patients
- Terminal illness, dementia or cognitive impairment;
- Pregnancy
- Surgery or hospital admission in the previous 3 months
- Hematological diseases that could interfere in HbA1c determination
- Presence of any condition that limits the participation in the study
- Participation in a clinical trial or receive a social prescription of diet or physical activity.
Key Trial Info
Start Date :
October 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
232 Patients enrolled
Trial Details
Trial ID
NCT04328363
Start Date
October 1 2020
End Date
December 1 2022
Last Update
June 4 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.